Cargando…
Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination
The development of a Pd(II)-catalyzed enantioselective fluorination of C(sp(3))–H bonds would offer a new approach to making chiral organofluorines. However, such a strategy is particularly challenging because of the difficulty in differentiating prochiral C(sp(3))–H bonds through Pd(II)-insertion,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289870/ https://www.ncbi.nlm.nih.gov/pubmed/29892027 http://dx.doi.org/10.1038/s41557-018-0048-1 |
_version_ | 1783379990097690624 |
---|---|
author | Park, Hojoon Verma, Pritha Hong, Kai Yu, Jin-Quan |
author_facet | Park, Hojoon Verma, Pritha Hong, Kai Yu, Jin-Quan |
author_sort | Park, Hojoon |
collection | PubMed |
description | The development of a Pd(II)-catalyzed enantioselective fluorination of C(sp(3))–H bonds would offer a new approach to making chiral organofluorines. However, such a strategy is particularly challenging because of the difficulty in differentiating prochiral C(sp(3))–H bonds through Pd(II)-insertion, as well as the sluggish reductive elimination involving Pd–F bonds. Here, we report the development of a Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination using a chiral transient directing group strategy. In this work, a bulky, amino amide transient directing group was developed to control the stereochemistry of C–H insertion step and selectively promote C(sp(3))–F reductive elimination pathway from Pd(IV)–F intermediate. Stereochemical analysis revealed that while the desired C(sp(3))–F formation proceeds via an inner-sphere pathway with retention of configuration, the undesired C(sp(3))–O formation occurs through an S(N)2-type mechanism. The elucidation of the dual mechanism allows us to rationalize the profound ligand effect on controlling reductive elimination selectivity from high-valent Pd species. |
format | Online Article Text |
id | pubmed-6289870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-62898702018-12-12 Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination Park, Hojoon Verma, Pritha Hong, Kai Yu, Jin-Quan Nat Chem Article The development of a Pd(II)-catalyzed enantioselective fluorination of C(sp(3))–H bonds would offer a new approach to making chiral organofluorines. However, such a strategy is particularly challenging because of the difficulty in differentiating prochiral C(sp(3))–H bonds through Pd(II)-insertion, as well as the sluggish reductive elimination involving Pd–F bonds. Here, we report the development of a Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination using a chiral transient directing group strategy. In this work, a bulky, amino amide transient directing group was developed to control the stereochemistry of C–H insertion step and selectively promote C(sp(3))–F reductive elimination pathway from Pd(IV)–F intermediate. Stereochemical analysis revealed that while the desired C(sp(3))–F formation proceeds via an inner-sphere pathway with retention of configuration, the undesired C(sp(3))–O formation occurs through an S(N)2-type mechanism. The elucidation of the dual mechanism allows us to rationalize the profound ligand effect on controlling reductive elimination selectivity from high-valent Pd species. 2018-06-11 2018-07 /pmc/articles/PMC6289870/ /pubmed/29892027 http://dx.doi.org/10.1038/s41557-018-0048-1 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms Reprints and permissions information is available at www.nature.com/reprints. |
spellingShingle | Article Park, Hojoon Verma, Pritha Hong, Kai Yu, Jin-Quan Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination |
title | Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination |
title_full | Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination |
title_fullStr | Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination |
title_full_unstemmed | Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination |
title_short | Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination |
title_sort | controlling pd(iv) reductive-elimination pathways enables pd(ii)-catalyzed enantioselective c(sp(3))–h fluorination |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289870/ https://www.ncbi.nlm.nih.gov/pubmed/29892027 http://dx.doi.org/10.1038/s41557-018-0048-1 |
work_keys_str_mv | AT parkhojoon controllingpdivreductiveeliminationpathwaysenablespdiicatalyzedenantioselectivecsp3hfluorination AT vermapritha controllingpdivreductiveeliminationpathwaysenablespdiicatalyzedenantioselectivecsp3hfluorination AT hongkai controllingpdivreductiveeliminationpathwaysenablespdiicatalyzedenantioselectivecsp3hfluorination AT yujinquan controllingpdivreductiveeliminationpathwaysenablespdiicatalyzedenantioselectivecsp3hfluorination |